financetom
Business
financetom
/
Business
/
Washington Trust Bancorp Q3 Adjusted Earnings Fall, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Washington Trust Bancorp Q3 Adjusted Earnings Fall, Revenue Rises
Oct 20, 2025 1:45 PM

04:27 PM EDT, 10/20/2025 (MT Newswires) -- Washington Trust Bancorp ( WASH ) late Monday reported Q3 adjusted earnings per diluted share of $0.56 , down from $0.64 a year earlier.

Four analysts polled by FactSet expected $0.46.

Revenue, expressed as the sum of net interest income and noninterest income, for the quarter ended Sept. 30 was $56.5 million, up from $48.5 million a year earlier.

One analyst surveyed by FactSet expected $56.4 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Outbrain Insider Sold Shares Worth $373,875, According to a Recent SEC Filing
Outbrain Insider Sold Shares Worth $373,875, According to a Recent SEC Filing
Dec 18, 2024
05:07 PM EST, 12/18/2024 (MT Newswires) -- Yaron Galai, Director, Co-Founder and Board Chair, on December 17, 2024, sold 50,000 shares in Outbrain ( OB ) for $373,875. Following the Form 4 filing with the SEC, Galai has control over a total of 3,457,521 shares of the company, with 3,457,521 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1454938/000145493824000238/xslF345X05/wk-form4_1734559397.xml ...
Savara Starts Biologics License Application Submission for Lung Disease Treatment Candidate
Savara Starts Biologics License Application Submission for Lung Disease Treatment Candidate
Dec 18, 2024
05:07 PM EST, 12/18/2024 (MT Newswires) -- Savara (SVRA) said late Wednesday it started a rolling submission of a biologics license application, or BLA, to the US Food and Drug Administration for Molbreevi, aimed at potentially treating autoimmune Pulmonary Alveolar Proteinosis, a rare lung disease. The clinical-stage biopharmaceutical company said it plans to finalize the BLA submission by the end...
Australia's NOVONIX joins US petition against China's unfair graphite pricing
Australia's NOVONIX joins US petition against China's unfair graphite pricing
Dec 18, 2024
Dec 19 (Reuters) - Australia's NOVONIX Ltd ( NVX ) said on Thursday it had participated in a petition urging U.S. authorities to investigate China's alleged dumping of battery-grade graphite at unfair prices, potentially harming domestic producers. (Reporting by Roshan Thomas in Bengaluru; Editing by Shreya Biswas ) ...
City Office REIT Reports Lease Extension for Dallas Property
City Office REIT Reports Lease Extension for Dallas Property
Dec 18, 2024
05:05 PM EST, 12/18/2024 (MT Newswires) -- City Office REIT ( CIO ) said late Wednesday that an existing tenant at the company's Terraces property in Dallas expanded its space by 16,000 square feet to 60,000 square feet and extended the lease through 2036. The property is now 95% leased, including the expanded space, which is expected to begin in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved